HomeStocksNATCOPHARM

N

Natco Pharma

NATCOPHARM Share Price

Pharmaceuticals

1,436.25

-1.25 (-0.09%) profit

Last Updated on 11 Oct 2024 at 15:58

TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

NATCOPHARM Stock Performance

Markets Today

High

1,446.00

Low

1,427.00

Open at

1,436.00

Prev Close

1,436.25

Volumes

3,66,413

Avg Price

1,435.04

Lower Circuit

1,149.00

Upper Circuit

1,723.50

Last Traded Details

Quantity

25

Time

15:58:08

Price Movement

1,427.00
1,436.25
1,446.00
Loss 0.65%down side
up side0.67% profit

Historical Performance

3 M High

1,639.00

3 M Low

1,170.40

1 Yr High

1,639.00

1 Yr Low

724.20

3 Yr High

1,639.00

3 Yr Low

502.00

5 Yr High

1,639.00

5 Yr Low

402.55

1-Year Performance

724.20
1,436.25
1,639.00
loss0.65%down side
up side0.67% profit

NATCOPHARM Share Price History

NATCOPHARM share price in last 10 trading sessions

No data

Sorry, No Data Available at this Moment!


NATCOPHARM Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

25,701

PE Ratio

16.00

PB Ratio

4.39

Dividend Yield

0.66

ROE

23.72

ROCE

29.92

Book Value (₹)

326.79

Face Value (₹)

2.00


Share Holding Pattern

Held ByJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Promoters
49.71%49.71%49.71%49.71%49.76%
Domestic Institutional Investors (DII)
7.87%9.70%11.25%14.01%15.15%
Foreign Institutional Investors (FII)
17.45%16.14%13.72%12.82%11.02%
Public Investors
24.97%24.45%25.32%23.46%24.07%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


NATCOPHARM Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


NATCOPHARM Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA00Bullish
10-SMA00Bullish
20-SMA00Bullish
50-SMA00Bullish
100-SMA00Bullish
200-SMA00Bullish

Technical Indicators

IndicatorValueAction
RSI(14)00Bullish
ATR(14)00Bullish
STOCH(14)00Bullish
STOCH RSI(14)00Bullish
MACD(12,26)00Bullish
ADX(14)00Bullish

Summary of Technical Indicators for NATCOPHARM


NATCOPHARM Financials

Income Statement

In Crores

Yearly StatementMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue4,1272,8122,0442,1562,022
Expenses2,2471,7721,6811,4461,332
Operating Profit1,751936264606583
Operating Profit Margin %44%35%14%30%30%
Other Income12810599104107
Interest1915181322
Depreciation187164143117100
Profit Before Tax1,674862202580569
Tax %17%17%16%24%19%
Net Profit1,388715170442458
EPS773992425

Balance Sheet

In Crores

Yearly Balance SheetMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Share Capital3637373736
Reserve & Surplus5,8174,8374,2274,0853,737
Minority Interest000211
Non Current Liabilities80101135143118
Current Liabilities973683710526685
Total Liabilities1,053784846669803
Fixed Assets2,4912,4272,3122,0231,584
Capital Work in Progress13764130223518
Investments539392308304112
Other Assets3,7392,7742,3602,2422,373
Total Assets6,9065,6575,1094,7924,588

Cash Flow

In Crores

Yearly Cash FlowMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating Activities1,21284946299417
Investing Activities-1,026-4654-107-175
Financing Activities-247-36335-186-251
Net Cash Flow-6221856-8

Corporate Actions

No Data

Sorry, No Corporate Actions at this Moment!


NATCOPHARM Revenue Growth

All values are in Crores

Profit

Revenue

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2023-243,569
51.8% profit
1,307
105.09% profit
FY 2022-232,351
32.99% profit
637
358.02% profit
FY 2021-221,768
6.91% profit
139
-55.06% Loss

NATCOPHARM Similar Stocks

View All arrow

Top Gainers Today

View All Gainers arrow

Top Losers Today

View All Losers arrow

NSE Indices Today

All NSE Indices arrow

BSE Indices Today

All BSE Indices arrow

Open IPOs

View All arrow
No Data

Sorry, No Data Available at this Moment!



FAQs

Natco Pharma share price as of today is ₹ 1,436.25 as on 11 Oct 2024 at 15:58.
The 52W high of Natco Pharma is ₹ 1,638.35 and 52W low is ₹ 725.00 as of 11 Oct 2024 at 15:58.
The past returns of Natco Pharma share are -
  • Past 1 year: 68.80%
  • Past 3 years: 60.76%
  • Past 5 years: 156.29%
The PE and PB ratio of Natco Pharma stands at 16.00 and 4.39 respectively as on 11 Oct 2024 at 15:58.
The EPS of Natco Pharma is 37.32 for the quarter ended Jun 2024 and 77.34 for the financial year 2023-24.
The shareholding pattern of Natco Pharma is as follows:
  • DIIs - 7.87%
  • FII - 17.45%
  • Promoters - 49.71%
  • Public Investors 24.97%
  • Goverenment - 0.00%
Yes, you can buy shares of Natco Pharma online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Natco Pharma stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Natco Pharma share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Natco Pharma.
You can easily buy the shares of Natco Pharma even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in NATCOPHARM
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2024 Moneylicious Securities Private Limited. All rights reserved. CIN - U74999WB2012PTC184187 Moneylicious Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Office No. 14D, 4th Floor, Shri Krishna Chambers, 78, Bentick Street, Kolkata - 700001, West Bengal, India.
Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Moneylicious Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


DHAN is a brand owned by Moneylicious Securities Private Limited. All DHAN clients are registered under Moneylicious Securities Private Limited. Clients are advised to refer to our company as Moneylicious Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / Moneylicious / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Moneylicious Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Saarthi 2.0 Mobile App for Investors